☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Pregabalin and Gabapentin to be Controlled Drugs

The Home Office has announced that, following a consultation, Pregabalin and gabapentin are to be reclassified as Controlled Drugs with effect from April 2019.

Pregabalin and gabapentin have been associated with medicinal misuse, illegal diversion and addiction. Both drugs have seen increased use in recent years as well as increased numbers of fatalities related to drug related poisoning.

Both drugs will be reclassified as Schedule 3 controlled drugs meaning prescribers will now need to physically sign prescriptions which will only be valid in pharmacies for 28 days. As such they will no longer be sent electronically via EPS. The drugs will also be reclassified as class C making it illegal to possess pregabalin and gabapentin without a prescription and it will be illegal to supply or sell them to others.

These changes will come into force in April 2019 to allow time for healthcare systems and providers to implement the necessary changes to prescribing systems and processes.

Action: Clinicians should be aware of this change and ensure staff who aid in preparing prescriptions are notified. Systems for processing and handling controlled drug prescriptions may need to be reviewed and updated in light of this change.

Share 'Pregabalin and Gabapentin to be Controlled Drugs' by emailShare 'Pregabalin and Gabapentin to be Controlled Drugs' on FacebookShare 'Pregabalin and Gabapentin to be Controlled Drugs' on TwitterShare 'Pregabalin and Gabapentin to be Controlled Drugs' on LinkedInShare 'Pregabalin and Gabapentin to be Controlled Drugs' on reddit


One Comment to “Pregabalin and Gabapentin to be Controlled Drugs”

  1. You never know, the proposed CD by ETP may have started by then after what, four years? I believe there is a pilot currently but I've not seen a live prescription yet. Fingers crossed or this will be as much a pain as Tramadol moving to be a CD was.

    Comment by MrHunnybun — October 18, 2018 #

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.